FORMAT
BOOKS
PACKAGES
EDITION
PUBLISHER
CONTENT TYPE
Act
Admin Code
Announcements
Bill
Book
CADD File
CAN
CEU
Charter
Checklist
City Code
Code
Commentary
Comprehensive Plan
Conference Paper
County Code
Course
DHS Documents
Document
Errata
Executive Regulation
Federal Guideline
Firm Content
Guideline
Handbook
Interpretation
Journal
Land Use and Development
Law
Legislative Rule
Local Amendment
Local Code
Local Document
Local Regulation
Local Standards
Manual
Model Code
Model Standard
Notice
Ordinance
Other
Paperback
PASS
Periodicals
PIN
Plan
Policy
Product
Product - Data Sheet
Program
Provisions
Requirements
Revisions
Rules & Regulations
Standards
State Amendment
State Code
State Manual
State Plan
State Standards
Statute
Study Guide
Supplement
Sustainability
Technical Bulletin
All
|
Description of 20/30369896 DC 2020This document defines terms and provides general requirements for the testing of cellular therapeutic products intended for human use. This document also provides considerations for the characterization and testing of cellular therapeutic products, including approaches to select and design analytical methods that are fit for purpose, and considerations for setting specifications for the analytical methods. Such considerations can be used to establish critical quality attributes (CQAs) for a cellular therapeutic product. Aspects of this document are applicable to starting materials (including those for tissue engineered products) and intermediates of cellular therapeutic products. This document excludes tissues used in transplantation.
About BSIBSI Group, also known as the British Standards Institution is the national standards body of the United Kingdom. BSI produces technical standards on a wide range of products and services and also supplies certification and standards-related services to businesses. |
GROUPS
|